ABEONA THERAPEUTICS INC. Financing Cash Flow
ABEONA THERAPEUTICS INC. (ABEO) reported Financing Cash Flow of -$5.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- ABEONA THERAPEUTICS INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$3.33M, a 131.78% decline year-over-year.
- ABEONA THERAPEUTICS INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$2.22M, a 132.83% decline year-over-year.
- ABEONA THERAPEUTICS INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $3.61M, a 31.99% decline year-over-year.
- ABEONA THERAPEUTICS INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $5.16M.
- ABEONA THERAPEUTICS INC. net cash provided by (used in) financing activities for fiscal 2025 was $26.04M, a 74.99% decline from fiscal 2024.
- ABEONA THERAPEUTICS INC. net cash provided by (used in) financing activities for fiscal 2024 was $104.14M, a 181.02% increase from fiscal 2023.
- ABEONA THERAPEUTICS INC. net cash provided by (used in) financing activities for fiscal 2023 was $37.06M, a 14.17% decline from fiscal 2022.
- ABEONA THERAPEUTICS INC. net cash provided by (used in) financing activities for fiscal 2022 was $43.17M, a 73.66% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$5.56M 10-Q · filed 2026-08-13 | -$1.94M derived: sum of 3 quarters · filed 2026-08-13 | $3.22M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$2.22M 10-Q · filed 2026-05-13 | $1.39M derived: sum of 2 quarters · filed 2026-05-13 | $6.55M derived: sum of 3 quarters · filed 2026-05-13 | $17.05M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $8.78M derived: sum of 2 quarters · filed 2026-03-17 | $19.27M derived: sum of 3 quarters · filed 2026-08-13 | $26.04M 10-K · filed 2026-03-17 |
| 2025-09-30 | $5.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $15.66M derived: sum of 2 quarters · filed 2026-08-13 | $22.43M 10-Q · filed 2025-11-12 | $27.74M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $10.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $17.26M 10-Q · filed 2026-08-13 | $22.58M derived: sum of 3 quarters · filed 2026-08-13 | $22.28M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $6.77M 10-Q · filed 2026-05-13 | $12.08M derived: sum of 2 quarters · filed 2026-05-13 | $11.78M derived: sum of 3 quarters · filed 2026-05-13 | $85.47M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $5.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $5.01M derived: sum of 2 quarters · filed 2026-03-17 | $78.70M derived: sum of 3 quarters · filed 2026-03-17 | $104.14M 10-K · filed 2026-03-17 |
| 2024-09-30 | -$299.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $73.39M derived: sum of 2 quarters · filed 2025-11-12 | $98.83M 10-Q · filed 2025-11-12 | $106.29M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $73.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $99.12M 10-Q · filed 2025-08-14 | $106.59M derived: sum of 3 quarters · filed 2025-08-14 | $129.57M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $25.44M 10-Q · filed 2025-05-15 | $32.91M derived: sum of 2 quarters · filed 2025-05-15 | $55.88M derived: sum of 3 quarters · filed 2025-05-15 | $62.50M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $7.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $30.44M derived: sum of 2 quarters · filed 2025-03-20 | $37.06M derived: sum of 3 quarters · filed 2025-03-20 | $37.06M 10-K · filed 2025-03-20 |
| 2023-09-30 | $22.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $29.59M derived: sum of 2 quarters · filed 2024-11-14 | $29.59M 10-Q · filed 2024-11-14 | $72.36M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $6.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $6.61M 10-Q · filed 2024-08-12 | $49.38M derived: sum of 3 quarters · filed 2024-08-12 | $53.57M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$4.00K 10-Q · filed 2024-05-15 | $42.76M derived: sum of 2 quarters · filed 2024-05-15 | $46.95M derived: sum of 3 quarters · filed 2024-05-15 | |
| 2022-12-31 | $42.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $46.95M derived: sum of 2 quarters · filed 2024-03-18 | $43.17M 10-K · filed 2024-03-18 | |
| 2022-09-30 | $4.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $407.00K 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | -$3.78M 10-Q · filed 2023-08-08 | |||
| 2021-12-31 | $16.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $16.50M derived: sum of 2 quarters · filed 2023-03-29 | $18.98M derived: sum of 3 quarters · filed 2023-03-29 | $24.86M 10-K · filed 2023-03-29 |
| 2021-09-30 | $173.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.65M derived: sum of 2 quarters · filed 2022-11-14 | $8.53M 10-Q · filed 2022-11-14 | $8.53M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $8.36M 10-Q · filed 2022-08-11 | $8.36M derived: sum of 3 quarters · filed 2022-08-11 | $8.36M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $5.88M 10-Q · filed 2022-05-13 | $5.88M derived: sum of 2 quarters · filed 2022-05-13 | $5.88M derived: sum of 3 quarters · filed 2022-05-13 | |
| 2020-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $3.00K derived: sum of 2 quarters · filed 2022-03-31 | $1.94M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.93M 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $1.93M 10-Q · filed 2021-07-28 | |||
| 2019-12-31 | $96.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $100.87M derived: sum of 2 quarters · filed 2021-03-24 | $113.87M derived: sum of 3 quarters · filed 2021-03-24 | $113.90M 10-K · filed 2021-03-24 |
| 2019-09-30 | $4.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $17.35M derived: sum of 2 quarters · filed 2020-11-09 | $17.38M 10-Q · filed 2020-11-09 | $17.37M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $13.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $13.04M 10-Q · filed 2020-08-10 | $13.03M derived: sum of 3 quarters · filed 2020-08-10 | $16.11M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $28.00K 10-Q · filed 2020-05-06 | $27.00K derived: sum of 2 quarters · filed 2020-05-06 | $3.11M derived: sum of 3 quarters · filed 2020-05-06 | $3.68M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $3.08M derived: sum of 2 quarters · filed 2020-03-16 | $3.65M derived: sum of 3 quarters · filed 2020-03-16 | $5.48M 10-K · filed 2020-03-16 |
| 2018-09-30 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $3.65M derived: sum of 2 quarters · filed 2019-11-12 | $5.48M 10-Q · filed 2019-11-12 | $92.74M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | $570.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $2.40M 10-Q · filed 2019-08-09 | $89.66M derived: sum of 3 quarters · filed 2020-03-16 | $94.72M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | $1.83M 10-Q · filed 2019-05-10 | $89.09M derived: sum of 2 quarters · filed 2020-03-16 | $94.15M derived: sum of 3 quarters · filed 2020-03-16 | $94.23M derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | $87.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $92.32M derived: sum of 2 quarters · filed 2020-03-16 | $92.40M derived: sum of 3 quarters · filed 2020-03-16 | $92.40M 10-K · filed 2020-03-16 |
| 2017-09-30 | $5.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $5.14M derived: sum of 2 quarters · filed 2018-11-09 | $5.14M 10-Q · filed 2018-11-09 | $46.51M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $85.00K 10-Q · filed 2018-08-09 | $41.45M derived: sum of 3 quarters · filed 2019-03-18 | |
| 2017-03-31 | $1.00K 10-Q · filed 2018-05-10 | $41.37M derived: sum of 2 quarters · filed 2019-03-18 | ||
| 2016-12-31 | $41.37M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $42.54M 10-K · filed 2019-03-18 | ||
| 2016-09-30 | $1.17M 10-Q · filed 2017-11-14 | |||
| 2014-09-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $250.00K 10-Q · filed 2014-11-14 | ||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $18.00K derived: sum of 2 quarters · filed 2014-11-14 | $29.00K 10-K · filed 2014-03-26 | |
| 2013-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $29.00K 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | $11.00K 10-Q · filed 2014-08-14 | |||
| 2012-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $1.90M derived: sum of 2 quarters · filed 2014-03-26 | $1.90M 10-K · filed 2014-03-26 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-14 | |||
| 2011-12-31 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20 | $3.08M derived: sum of 2 quarters · filed 2013-03-20 | $3.08M 10-K · filed 2013-03-20 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | ||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-15 | |||
| 2010-12-31 | $7.25M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-23 | $7.30M derived: sum of 2 quarters · filed 2012-03-23 | $13.29M 10-K · filed 2012-03-23 | |
| 2010-09-30 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $6.04M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $5.99M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |